http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2877070-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8205ec6ee1cd95eb60a03826535bad97 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2019-0448 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2323-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2323-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2323-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-133302 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-133726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F2202-023 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L79-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-1007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-1003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-1042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-133788 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-133723 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-1337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-1334 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-1337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-1334 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L79-08 |
| filingDate | 2015-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a81cc54afbc521a77e7f4f245358c27d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01d05b72ba0a1d9156475357f006ee33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ead0fcbffd7fc9213812fa50d6a4cd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a44e32c9f921afc15380cabb2cf2f38 |
| publicationDate | 2021-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2877070-T3 |
| titleOfInvention | Liquid crystal display element, liquid crystal alignment film and liquid crystal alignment treatment agent |
| abstract | A liquid crystal display device, which is in a transparent state when no voltage is applied and in a disperse state when a voltage is applied, and comprising a liquid crystal layer formed by arranging a liquid crystal composition containing a polymerizable compound which is subjected to an ultraviolet ray polymerization reaction, between a pair of substrates provided with an electrode, and irradiating the liquid crystal composition with ultraviolet rays and curing it in such a state that the liquid crystal composition exhibits partially or fully liquid crystallinity, and at least one of the substrates is provided with a liquid crystal alignment film for vertically aligning a liquid crystal, wherein the liquid crystal alignment film is a liquid crystal alignment film obtained from of a liquid crystal alignment agent containing a solvent and a polymer that t It has a side chain structure (first side chain structure) represented by the following formula [1-1] or [1-2] and a side chain structure (second side chain structure) represented by the following formula [2] : **(See formula)** where X1 and X3 are each independently at least one linking group selected from the group consisting of a single bond, -(CH2)a- (where a is an integer from 1 to 15), -O-, -CH2O-, -COO- and -OCO-; X2 is a single bond or -(CH2)b- (where b is an integer from 1 to 15); X4 is at least one bivalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, or a C17-51 bivalent organic group having a steroid skeleton, with the proviso that one atom of optional hydrogen in the cyclic group may be substituted with a C1-3 alkyl group, a C1-3 alkoxy group, a fluorine-containing C1-3 alkyl group, a fluorine-containing C1-3 alkoxy group or a fluorine atom; X5 is at least one cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, with the proviso that an optional hydrogen atom in such a cyclic group may be substituted with a group C1-3 alkyl, a C1-3 alkoxy group, a fluorine-containing C1-3 alkyl group, a fluorine-containing C1-3 alkoxy group or a fluorine atom; n is an integer from 0 to 4; and X6 is at least one member selected from the group consisting of a C1-18 alkyl group, a fluorine-containing C1-18 alkyl group, a C1-18 alkoxy group and a fluorine-containing C1-18 alkoxy group; -x7-x8 [1-2] where X7 is at least one linking group selected from the group consisting of a single bond, -O-, -CH2O-, -CONH-, -NHCO-, -CON(CH3) -, -N(CH3)CO-, -COO- and -OCO-; and X8 is a C8-22 alkyl group or a fluorine-containing C6-18 alkyl group; -Y1-Y2-Y3-Y4 [2] wherein Y1 and Y3 are each independently at least one linking group selected from the group consisting of a single bond, -O-, -NH-, -N(CH3)- , -CH2O-, -CONH-, -NHCO-, -CON(CH3)-, -N(CH3)CO-, -COO- and -OCO-; Y2 is a C1-18 alkylene group or a C6-24 organic group having at least one cyclic group selected from the group consisting of a benzene ring, a cyclocyclohexane ring and a heterocyclic ring, with the proviso that an atom of Optional hydrogen in such a cyclic group may be substituted with a C1-3 alkyl group, a C1-3 alkoxy group, a fluorine-containing C1-3 alkyl group, a fluorine-containing C1-3 alkoxy group or a carbon atom. fluorine; and Y4 is at least one member selected from the group consisting of structures represented by the following formulas [2-a] to [2-g]: **(See formula)** where Ya is a hydrogen atom or a ring of benzene; Yb is a single bond, or at least one cyclic group selected from the group consisting of benzene ring, cyclohexane ring, and heterocyclic ring; and Yc is at least one member selected from the group consisting of a C1-18 alkyl group, a C1-18 fluorine-containing alkyl group, a C1-18 alkoxy group, and a C1-18 fluorine-containing alkoxy group, wherein the liquid crystal aligning agent is a liquid crystal aligning agent containing a polyimide precursor obtained by a reaction of a diamine component containing a diamine having a side chain structure of the above formula [1-1] or [ 1-2] and a diamine having the side chain structure represented by the above formula [2], and a tetracarboxylic acid component, or a polyimide obtained by imidizing the polyimide precursor, wherein the liquid crystal aligning agent contains at least one generating agent selected from the group consisting of a photoradical generator, a photoacid generator, and a photobase generator, wherein the liquid crystal alignment agent contains a compound having a At least one member selected from the group consisting of structures represented by the following formulas [b-1] to [b-8]: **(See formula)** where B1 is a hydrogen atom or a benzene ring, B2 is at least one cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring, and a heterocyclic ring, and B3 is at least one selected from the group consisting of a C1-8 alkyl group, a C1 alkyl group -18 containing fluorine, a C1-18 alkoxy group and a C1-18 alkoxy group containing fluorine, and wherein the liquid crystal alignment agent contains a compound having at least one group selected from the group consisting of a group epoxy, an isocyanate group, an oxetane group, a cyclocarbonate group, a hydroxy group, a hydroxyalkyl group and a lower alkoxyalkyl group. |
| priorityDate | 2014-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 769.